US stocks end mixed; Dow and S&P 500 rise
US stocks ended mixed on Friday with the Dow and S&P 500 finishing higher.
The Dow put on 45.79 points, or 0.35 per cent, to 12,949.87.
The Nasdaq lost 8.07 points, or 0.27 per cent, to 2951.78.
The S&P 500 was 3.19 points, or 0.23 per cent, higher to 1361.23.
In news, the consumer price index increased 0.2 per cent in January, according to the Labor Department.
And the Conference Board Leading Economic Index for the US rose 0.4 per cent in January to 94.9.
In earnings, Heinz said net income for its third quarter was US$284.7 million or US$0.88 per share. In the same quarter a year earlier, it reported net income of US$273.8 million or US$0.84 per share. Shares rose US$2.37, or 4.55 per cent, to US$54.57.
Campbell Soup reported net income of US$205 million, or US$0.64 per share, for its second quarter, compared with US$239 million, or US$0.71 per share, in the same quarter a year earlier. Shares rose US$0.84, or 2.62 per cent, to US$32.90.
In Australia on Friday, the S&P/ASX 200 increased 14 points, or 0.33 per cent, to 4195.9 and the All Ords was up 16.1 points, or 0.38 per cent, to 4273.3.
Oil this morning was at US$103.24 per barrel and gold was at US$1725.90 per ounce. The Australian dollar was buying 107.68 US cents, 67.97 pence Sterling, 81.69 euro cents and 85.71 Japanese yen.
Published on: Monday, February 20, 2012blog comments powered by Disqus
Today on Switzer
Arminius Capital’s Marcel von Pfyffer looks at the recovery in the US economy, and what’s on the radar for interest rates. (Broadcast Wednesday 1 October 2014.)
Is the sell-off over? To discuss what we can expect on the stock market, and whether it’s in buying range, JB Were’s Mike Kendall joins Switzer TV. (Broadcast Wednesday 1 October 2014.)
Recent economic news from Europe in my view sends a message that authorities believe that there is a clear and present danger of deflation across the entire area.
The Dow dropped 238 points and Ebola was blamed, but there's a lot of other worrying stuff out there.
Are biotech stocks a good buy? Business commentator James Dunn looks at life science companies, one of the largest sectors on the ASX. (Broadcast Tuesday 30 September 2014.)
Happily retired and thinking of taking a leisurely cruise around the Mediterranean? Well, you might need to think again.